Actively Recruiting
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium
Led by Takeda · Updated on 2025-09-09
75
Participants Needed
9
Research Sites
79 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cytomegalovirus (CMV) is a common virus that infects many people. It can cause serious illness in people with weak immune systems especially in those undergoing transplants. Maribavir is a medicine approved for treating CMV infection in adults after transplant. The main aim of this study is to check the use of maribavir and learn how safe and effective in treating adults with CMV infection after transplant in Belgium in line with the Belgian reimbursement criteria. During the study, a participant's data will be collected for 2 years. The study does not have fixed visits to the hospital, but it is recommended collect data from routine visits and contacts.
CONDITIONS
Official Title
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant signed an informed consent form.
- Aged greater than or equal to (>=) 18 years at the time of consent.
- Received a hematopoietic stem cell transplant (HSCT) or solid organ transplant (SOT).
- Diagnosed with cytomegalovirus (CMV) infection or disease any time after the HSCT/SOT date.
- Starting maribavir for the first time according to Belgian reimbursement criteria.
You will not qualify if you...
- Participant treated with maribavir before the start of the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
Hôpital Erasme
Anderlecht, Belgium, 1070
Actively Recruiting
2
Institut Jules Bordet
Anderlecht, Belgium, 1070
Actively Recruiting
3
Cliniques Universitaires Saint-Luc
Brussels, Belgium, 1200
Actively Recruiting
4
UZA
Edegem, Belgium, 2640
Actively Recruiting
5
UZGent
Ghent, Belgium, 9000
Actively Recruiting
6
UZBrussel
Jette, Belgium, 1090
Actively Recruiting
7
UZLeuven
Leuven, Belgium, 3000
Actively Recruiting
8
CHU de Liège - site Sart Tilman
Liège, Belgium, 4000
Actively Recruiting
9
CHU UCL Namur - site Godinne
Yvoir, Belgium, 5530
Actively Recruiting
Research Team
T
Takeda Contact
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here